Solcoderm, solution for external use, 0.2 ml, 1 pc.
Solcoderm is for external use only; The procedure must be performed by a physician or qualified medical personnel under the supervision of a physician.
Before the procedure, the area of the affected skin is treated with ethyl alcohol or ether. Solcoderm is applied directly to the affected area of the skin. To apply the drug to the skin, use a special plastic applicator with sharp and blunt ends, available in the package. The sharp edge is used mainly for applying the drug to small affected areas of the skin; The blunt end is used to treat large lesions.
As an alternative method of applying the drug, the supplied glass capillary is used. Combined skin lesions with an area of 2-3 cm2 can also be treated using a glass capillary. To fill a glass capillary with the drug, it must be immersed in Solcoderm solution for several minutes. Particular care should be taken during application, avoiding applying too large volumes of Solcoderm solution and damaging the deep layers of tissue. It is necessary to apply as much solution as the tissue of the affected skin area absorbs.
Solcoderm is carefully applied to the affected area of skin with a plastic applicator or glass capillary and then distributed over the surface of the selected area of skin with light pressure using a plastic applicator until the solution completely penetrates the tissue. Over the next 3-5 minutes, it is necessary to carefully observe the changes occurring in the treated area: skin discoloration occurs with the appearance of a characteristic pale grayish or yellowish tint. The procedure should be repeated until the above changes in skin color occur.
When treating keratinized warts, the top layer of the stratum corneum should first be removed.
Affected areas of skin with a diameter of more than 10 mm are treated with Solcoderm only if it is established that only the top layer of skin is pathologically modified.
In the presence of numerous foci of skin lesions, treatment with Solcoderm should be carried out in several stages, with an interval of approximately 4 weeks. During each procedure, no more than 2-3 lesions with a total area of no more than 2-3 cm 2 can be treated.
Within a few days after the procedure, the treated area of skin becomes dark brown and dries out to form a scab. In case of unsatisfactory mummification of pathologically altered tissue, the procedure can be repeated after a few days.
In order to promote fixation and mummification of pathologically altered tissues that have undergone treatment, the affected areas should be treated 2-3 times a day with a swab moistened with a 70% solution of ethyl alcohol (especially after taking a bath or after washing).
Do not remove the scab by scraping or using mechanical means. The scab must fall off spontaneously, otherwise tissue healing processes may be disrupted and scars may form.
Solcoderm
Solcoderm is for external use only; The procedure must be performed by a physician or qualified medical personnel under the supervision of a physician.
Before the procedure, the area of the affected skin is treated with ethyl alcohol or ether. Solcoderm is applied directly to the affected area of the skin. To apply the drug to the skin, use a special plastic applicator with sharp and blunt ends, available in the package. The sharp edge is used mainly for applying the drug to small affected areas of the skin; The blunt end is used to treat large lesions.
As an alternative method of applying the drug, the supplied glass capillary is used. Combined skin lesions with an area of 2-3 cm2 can also be treated using a glass capillary. To fill a glass capillary with the drug, it must be immersed in Solcoderm solution for several minutes. Particular care should be taken during application, avoiding applying too large volumes of Solcoderm solution and damaging the deep layers of tissue. It is necessary to apply as much solution as the tissue of the affected skin area absorbs.
Solcoderm is carefully applied to the affected area of skin with a plastic applicator or glass capillary and then distributed over the surface of the selected area of skin with light pressure using a plastic applicator until the solution completely penetrates the tissue. Over the next 3-5 minutes, it is necessary to carefully observe the changes occurring in the treated area: skin discoloration occurs with the appearance of a characteristic pale grayish or yellowish tint. The procedure should be repeated until the above changes in skin color occur.
When treating keratinized warts, the top layer of the stratum corneum should first be removed.
Affected areas of skin with a diameter of more than 10 mm are treated with Solcoderm only if it is established that only the top layer of skin is pathologically modified.
In the presence of numerous foci of skin lesions, treatment with Solcoderm should be carried out in several stages, with an interval of approximately 4 weeks. During each procedure, no more than 2-3 lesions with a total area of no more than 2-3 cm2 can be treated.
Within a few days after the procedure, the treated area of skin becomes dark brown and dries out to form a scab. In case of unsatisfactory mummification of pathologically altered tissue, the procedure can be repeated after a few days.
In order to promote fixation and mummification of pathologically altered tissues that have undergone treatment, the affected areas should be treated 2-3 times a day with a swab moistened with a 70% solution of ethyl alcohol (especially after taking a bath or after washing).
Do not remove the scab by scraping or using mechanical means. The scab must fall off spontaneously, otherwise tissue healing processes may be disrupted and scars may form.
Pharmacokinetics
The complex effect on the affected area of the skin of Solcoderm components - nitric acid, copper nitrate and organic acids (acetic, lactic, oxalic acids) - ensures rapid devitalization and fixation of the pathologically altered tissue area that has undergone treatment.
During therapy with Solcoderm, no significant absorption of active substances through the skin is observed; Taking into account the minimum volumes of the therapeutic dose, there is no need to worry about the systemic effect of the drug on the body.
Solcoderm®
For external use only; the procedure must be performed by a physician or medical personnel under the supervision of a physician.
Before the procedure, the area of the affected skin is treated with ethyl alcohol or ether. Solcoderm is applied directly to the affected area of the skin. To apply the drug to the skin, use a special plastic applicator with sharp and blunt ends, available in each package. The sharp edge is used mainly for applying the drug to small affected areas of the skin; The blunt end is used to treat large lesions.
As an alternative method of applying the drug, the supplied glass capillary is used. Combined skin lesions with an area of 2-3 cm2 can also be treated using a glass capillary. To fill a glass capillary with the drug, it must be immersed in Solcoderm solution for several minutes. Particular care should be taken during application, avoiding applying too large volumes of Solcoderm solution and damaging the deep layers of tissue. It is necessary to apply as much solution as the tissue of the affected skin area absorbs. Solcoderm is carefully applied to the affected area of skin with a plastic applicator or glass capillary and then evenly distributed over the surface of the selected area of skin with light pressure using a plastic applicator until the solution completely penetrates the tissue. Over the next 3-5 minutes, it is necessary to carefully observe the changes occurring in the treated area: skin discoloration occurs with the appearance of a characteristic pale gray or yellowish tint. The procedure should be repeated until the above changes in skin color occur.
When treating keratinized warts, the top layer of the stratum corneum should first be removed.
Affected areas of skin with a diameter of more than 10 mm are treated with Solcoderm only if it is established that only the top layer of skin is pathologically modified.
In the presence of numerous foci of skin lesions, treatment with Solcoderm should be carried out in several stages, with an interval of approximately 4 weeks. During each procedure, no more than 2-3 lesions with a total area of no more than 2-3 cm2 can be treated.
During the procedure, moderate transient erythema and the appearance of a white ischemic ring on healthy skin around the site of application of the drug may be observed. These phenomena are considered normal and do not require special treatment. In cases of pain, treatment should be interrupted immediately. Within a few days after the procedure, the treated area of skin becomes dark brown and dries out to form a scab. In case of unsatisfactory mummification of pathologically altered tissue, the procedure can be repeated after a few days.
In order to promote fixation and mummification of pathologically altered tissues that have undergone treatment, the affected areas should be treated 2-3 times a day with a swab moistened with 70% alcohol (especially after taking a bath or after washing).
Composition and release form
| Solution for external use | 1 ml |
| nitric acid 70% | 580.7 mg |
| acetic acid 99% | 41.1 mg |
| oxalic acid dihydrate | 57.4 mg |
| lactic acid 90% | 4.5 mg |
| copper nitrate trihydrate | 48 mcg |
| distilled water | up to 1 ml |
in 0.2 ml ampoules complete with applicators and capillaries; 1 set in box.
Precautionary measures
Use on inflamed skin areas is not allowed. In cases of pain, treatment should be interrupted immediately. Using too high a dose can cause acid burns and damage deep layers of tissue. Special precautions should be taken when applying Solcoderm solution to the face, especially to the skin areas located near the eyes. If Solcoderm solution accidentally gets into the eye, it is necessary to immediately rinse the eye with a large amount of water or a weak alkaline solution, for example 1% sodium bicarbonate solution. Drops of Solcoderm solution that get on furniture or clothing must be washed off with water, since Solcoderm can destroy materials. After biopsy of the affected area of skin, it is recommended to wait 8-10 days before starting treatment. Special care is required when treating benign skin tumors that were previously treated with other drugs and methods.
Before discarding the ampoule, the remaining solution should be washed off in running water. The empty ampoule can be thrown into a waste container.
special instructions
Since the Solcoderm solution is chemically unstable after opening the ampoule, a new ampoule must be used for each therapeutic procedure. Before opening the ampoule, shake it and knock down the solution that gets into the upper part of the ampoule. The neck of the ampoule breaks along the line. Keep the opened ampoule strictly vertical by securing it in a special slot in the contour packaging for ampoules. When treating affected areas of the skin located next to the mucous membranes, incl. near the eyes, special precautions should be taken. If severe local irritation and severe itching occur in adjacent areas of the skin, it is recommended to use a cream containing steroid components or an ointment that has an anesthetic effect. Do not remove the scab by scraping or using mechanical means. The scab must fall off spontaneously, otherwise tissue healing processes may be disrupted and scars may form. Until the lesion treated with Solcoderm is completely healed (approximately 2–4 months after therapy), exposure to direct sunlight and UV radiation should be avoided.
Solcoderm solution external 0.2 ml No. 1
Contraindications
— Malignant skin tumors prone to metastasis (including malignant melanoma).
— Pronounced tendency to form scar tissue. Solcoderm cannot be used to remove freckles and keloid scars.
Directions for use and doses
Solcoderm is intended for external use only, the procedure must be carried out by a physician or qualified medical personnel under the supervision of a physician.
Before the procedure, the area of the affected skin is treated with ethyl alcohol or ether. Solcoderm is applied directly to the affected area of the skin. To apply the drug to the skin, use a special plastic applicator with sharp and blunt ends, available in the package. The sharp edge is used mainly for applying the drug to small affected areas of the skin, the blunt end is used to treat large lesions.
As an alternative method of applying the drug, the supplied glass capillary is used. Combined skin lesions with an area of 2-3 cm2 can also be treated using a glass capillary. To fill a glass capillary with the drug, it must be immersed in Solcoderm solution for several minutes. Particular care should be taken during application, avoiding applying too large volumes of Solcoderm solution and damaging the deep layers of tissue. It is necessary to apply as much solution as the tissue of the affected skin area absorbs.
Solcoderm is carefully applied to the affected area of skin with a plastic applicator or glass capillary and then distributed over the surface of the selected area of skin with light pressure using a plastic applicator until the solution completely penetrates the tissue. Over the next 3-5 minutes, it is necessary to carefully observe the changes occurring in the treated area: skin discoloration occurs with the appearance of a characteristic pale grayish or yellowish tint. The procedure should be repeated until the above changes in skin color occur.
When treating keratinized warts, the top layer of the stratum corneum should first be removed.
Affected areas of skin with a diameter of more than 10 mm are treated with Solcoderm only if it is established that only the top layer of skin is pathologically modified.
In the presence of numerous foci of skin lesions, treatment with Solcoderm should be carried out in several stages, with an interval of approximately 4 weeks. During each procedure, no more than 2-3 lesions with a total area of no more than 2-3 cm 2 can be treated.
Within a few days after the procedure, the treated area of skin becomes dark brown and dries out to form a scab. In case of unsatisfactory mummification of pathologically altered tissue, the procedure can be repeated after a few days.
In order to promote fixation and mummification of pathologically altered tissues that have undergone treatment, the affected areas should be treated 2-3 times a day with a swab moistened with a 70% solution of ethyl alcohol (especially after taking a bath or after washing).
Do not remove the scab by scraping or using mechanical means. The scab must fall off spontaneously, otherwise tissue healing processes may be disrupted and scars may form.
Side effects
Local reactions: short-term burning within a few minutes after application of the drug, moderate transient erythema and the temporary appearance of a white ischemic ring on healthy skin around the site of application of the drug (do not require special treatment), in very rare cases - changes in skin pigmentation and the formation of scar tissue.
Use during pregnancy and breastfeeding
Studies to study the possible effect of the drug on the body of women during pregnancy and lactation have not been conducted to date. Solcoderm can be used during pregnancy and lactation only in cases where the potential benefits of its use outweigh the possible risk to the fetus or child.
Experimental studies on animals have shown the absence of a risk factor for the fetus.
Interaction
No data.
Overdose
Symptoms: using Solcoderm in too large doses can lead to acid burns and damage to the deep layers of the skin. Treatment: An ulcer caused by an overdose is treated like a regular wound.
